Opus Genetics, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Opus Genetics, Inc. (IRD) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$2.08 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2020-10-29
- Opus Genetics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- Opus Genetics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Opus Genetics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2020-03-31 was -$2.08K, a 139.82% decline year-over-year.
- Opus Genetics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2019-12-31 was -$5.76K, a 149.47% decline year-over-year.
- Opus Genetics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2019 was $19.92K, a 48.99% decline from fiscal 2018.
- Opus Genetics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2018 was $39.05K.
- Opus Genetics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2017 was -$50.76K, a 525.91% decline from fiscal 2016.
- Opus Genetics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2016 was $11.92K, a 23.63% decline from fiscal 2015.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | -$2.08K 10-Q · filed 2020-10-29 | -$7.85K derived: sum of 4 quarters · filed 2020-10-29 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$2.08K 10-Q · filed 2020-08-14 | -$7.85K derived: sum of 3 quarters · filed 2020-08-14 | -$7.18K derived: sum of 4 quarters · filed 2020-10-29 |
| 2020-03-31 | -$2.08K 10-Q · filed 2020-05-07 | -$7.85K derived: sum of 2 quarters · filed 2020-05-07 | -$7.18K derived: sum of 3 quarters · filed 2020-10-29 | $12.60K derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-12-31 | -$5.76K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$5.09K derived: sum of 2 quarters · filed 2020-10-29 | $14.69K derived: sum of 3 quarters · filed 2020-10-29 | $19.92K 10-K · filed 2020-02-21 |
| 2019-09-30 | $669.00 10-Q · filed 2020-10-29 | $20.45K derived: sum of 2 quarters · filed 2020-10-29 | $25.68K 10-Q · filed 2020-10-29 | $37.34K derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | $19.78K 10-Q · filed 2020-08-14 | $25.02K 10-Q · filed 2020-08-14 | $36.67K derived: sum of 3 quarters · filed 2020-08-14 | $72.13K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $5.23K 10-Q · filed 2020-05-07 | $16.89K derived: sum of 2 quarters · filed 2020-05-07 | $52.35K derived: sum of 3 quarters · filed 2020-05-07 | $76.77K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $11.65K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $47.12K derived: sum of 2 quarters · filed 2020-02-21 | $71.54K derived: sum of 3 quarters · filed 2020-02-21 | $39.05K 10-K · filed 2020-02-21 |
| 2018-09-30 | $35.47K 10-Q · filed 2019-11-06 | $59.89K derived: sum of 2 quarters · filed 2019-11-06 | $27.40K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $24.42K 10-Q · filed 2019-08-07 | -$8.07K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | -$32.49K 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | -$50.76K 10-K · filed 2019-03-07 | |||
| 2016-12-31 | $11.92K 10-K · filed 2018-03-09 | |||
| 2015-12-31 | $15.61K 10-K · filed 2018-03-09 | |||
| 2014-12-31 | -$33.65K 10-K · filed 2017-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |